{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:25:07Z","timestamp":1790623507291,"version":"4.1.0"},"reference-count":41,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"unspecified","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["AHA-09CRP2251004"],"award-info":[{"award-number":["AHA-09CRP2251004"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["68633259"],"award-info":[{"award-number":["68633259"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2022,8,3]]},"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Cholesterol loading capacity (CLC) describes the ability of serum to deliver cholesterol to cells. It is linked to foam cell formation, a pivotal step in atherosclerotic plaque development. We evaluate the associations of CLC with coronary atherosclerosis presence, burden and cardiovascular risk in patients with rheumatoid arthritis (RA).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Coronary atherosclerosis (any, high-risk low-attenuation plaque and obstructive plaque) was evaluated with CT angiography in 141 patients. Participants were prospectively followed for 6.0\u00b12.4 years and cardiovascular events including cardiac death, myocardial infarction, unstable angina, stroke, claudication, revascularisation and hospitalised heart failure were recorded. CLC was quantified as intracellular cholesterol in human macrophages after incubation with patient serum.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>CLC was not linked to overall plaque presence or burden after adjustments for atherosclerotic cardiovascular disease (ASCVD) score, statin use and low-density lipoprotein cholesterol. However, CLC associated with presence and numbers of any, low-attenuation and obstructive plaques exclusively in biologic disease-modifying antirheumatic drugs (bDMARD) non-users (p for interaction \u22640.018). CLC associated with cardiovascular event risk overall after adjustments for ASCVD and number of segments with plaque (HR=1.76 (95% CI 1.16 to 2.67) per 1 SD increase in CLC, p=0.008). Additionally, bDMARD use modified the impact of CLC on event risk; CLC associated with events in bDMARD non-users (HR=2.52 (95% CI 1.36 to 4.65) per 1SD increase in CLC, p=0.003) but not users.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>CLC was linked to long-term cardiovascular event risk in RA and associated with high-risk low attenuation and obstructive coronary plaque presence and burden in bDMARD non-users. Its prospective validation as a predictive biomarker may be, therefore, warranted.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rmdopen-2022-002411","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T13:12:29Z","timestamp":1663333949000},"page":"e002411","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["Serum cholesterol loading capacity on macrophages is linked to coronary atherosclerosis and cardiovascular event risk in rheumatoid arthritis"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1065-1563","authenticated-orcid":false,"given":"George Athanasios","family":"Karpouzas","sequence":"first","affiliation":[{"name":"Internal Medicine\u2014Rheumatology, Lundquist Institute, Torrance, California, USA"},{"name":"Department of Rheumatology, Harbor-UCLA Medical Center, Torrance, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Papotti","sequence":"additional","affiliation":[{"name":"Department of Food and Drug, University of Parma, Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ormseth","sequence":"additional","affiliation":[{"name":"Internal Medicine\u2014Rheumatology, Lundquist Institute, Torrance, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Palumbo","sequence":"additional","affiliation":[{"name":"Department of Food and Drug, University of Parma, Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Internal Medicine, Lundquist Institute, Torrance, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pia","family":"Adorni","sequence":"additional","affiliation":[{"name":"University of Parma, Parma, Emilia-Romagna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Zimetti","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Parma, Parma, Emilia-Romagna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Budoff","sequence":"additional","affiliation":[{"name":"Internal Medicine, Lundquist Institute, Torrance, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Ronda","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Parma, Parma, Emilia-Romagna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"2025090312053779000_8.2.e002411.1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.34.20963"},{"key":"2025090312053779000_8.2.e002411.2","doi-asserted-by":"publisher","DOI":"10.1038\/343425a0"},{"key":"2025090312053779000_8.2.e002411.3","doi-asserted-by":"publisher","DOI":"10.1007\/978-90-481-8622-8_8"},{"key":"2025090312053779000_8.2.e002411.4","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/art.39039","article-title":"Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolism","volume":"67","author":"Ronda","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2025090312053779000_8.2.e002411.5","doi-asserted-by":"publisher","DOI":"10.1177\/1535370213503262"},{"key":"2025090312053779000_8.2.e002411.6","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1210\/jc.2018-02027","article-title":"High-Density lipoprotein function is reduced in patients affected by genetic or idiopathic hypogonadism","volume":"104","author":"Adorni","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2025090312053779000_8.2.e002411.7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jacl.2020.05.002","article-title":"Lipoprotein(a) concentration, genetic variants, apo(a) isoform size, and cellular cholesterol efflux in patients with elevated Lp(a) and coronary heart disease submitted or not to lipoprotein apheresis: An Italian case-control multicenter study on Lp(a)","volume":"14","author":"Stefanutti","year":"2020","journal-title":"J Clin Lipidol"},{"key":"2025090312053779000_8.2.e002411.8","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8120625","article-title":"HDL-mediated cholesterol efflux and plasma loading capacities are altered in subjects with metabolically- but not genetically driven non-alcoholic fatty liver disease (NAFLD)","volume":"8","author":"Di Costanzo","year":"2020","journal-title":"Biomedicines"},{"key":"2025090312053779000_8.2.e002411.9","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.777822","article-title":"Lipid-Laden Macrophages and Inflammation in Atherosclerosis and Cancer: An Integrative View","volume":"9","author":"Lee-Rueckert","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2025090312053779000_8.2.e002411.10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-84249-y","article-title":"Cholesterol loading suppresses the atheroinflammatory gene polarization of human macrophages induced by colony stimulating factors","volume":"11","author":"Lappalainen","year":"2021","journal-title":"Sci Rep"},{"key":"2025090312053779000_8.2.e002411.11","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203617"},{"key":"2025090312053779000_8.2.e002411.12","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200726"},{"key":"2025090312053779000_8.2.e002411.13","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/art.41293","article-title":"Biologics may prevent cardiovascular events in rheumatoid arthritis by inhibiting coronary plaque formation and stabilizing high-risk lesions","volume":"72","author":"Karpouzas","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2025090312053779000_8.2.e002411.14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14740338.2016.1218469","article-title":"Cardiovascular outcomes and tumour necrosis factor antagonists in chronic inflammatory rheumatic disease: a focus on rheumatoid arthritis","volume":"15","author":"Tocci","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"2025090312053779000_8.2.e002411.15","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/acr.23737","article-title":"Tocilizumab and the risk of cardiovascular disease: direct comparison among biologic disease-modifying antirheumatic drugs for rheumatoid arthritis patients","volume":"71","author":"Xie","year":"2019","journal-title":"Arthritis Care Res"},{"key":"2025090312053779000_8.2.e002411.16","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-018-1669-x","article-title":"Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study","volume":"20","author":"Lee","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2025090312053779000_8.2.e002411.17","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9072157","article-title":"Anti-atherogenic modification of serum lipoprotein function in patients with rheumatoid arthritis after tocilizumab treatment, a pilot study","volume":"9","author":"Greco","year":"2020","journal-title":"J Clin Med"},{"key":"2025090312053779000_8.2.e002411.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.07.031"},{"key":"2025090312053779000_8.2.e002411.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcct.2014.07.003"},{"key":"2025090312053779000_8.2.e002411.20","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(90)90282-T"},{"key":"2025090312053779000_8.2.e002411.21","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s10554-016-0957-2","article-title":"Dynamic change of high-risk plaque detected by coronary computed tomographic angiography in patients with subclinical coronary artery disease","volume":"32","author":"Iwasaki","year":"2016","journal-title":"Int J Cardiovasc Imaging"},{"key":"2025090312053779000_8.2.e002411.22","article-title":"Serum cholesterol loading capacity on macrophages is regulated by seropositivity and C-reactive protein in rheumatoid arthritis patients","author":"Karpouzas","year":"2022","journal-title":"Rheumatology"},{"key":"2025090312053779000_8.2.e002411.23","first-page":"S49","article-title":"ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American heart association Task force on practice guidelines","volume":"2014","author":"Goff","year":"2013","journal-title":"Circulation"},{"key":"2025090312053779000_8.2.e002411.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.08.001"},{"key":"2025090312053779000_8.2.e002411.25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.amjcard.2017.10.018","article-title":"Relation of coronary artery calcium and extra-coronary aortic calcium to incident hypertension (from the multi-ethnic study of atherosclerosis)","volume":"121","author":"Aladin","year":"2018","journal-title":"Am J Cardiol"},{"key":"2025090312053779000_8.2.e002411.26","doi-asserted-by":"publisher","DOI":"10.1038\/nri3520"},{"key":"2025090312053779000_8.2.e002411.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2013.04.001"},{"key":"2025090312053779000_8.2.e002411.28","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M501759200"},{"key":"2025090312053779000_8.2.e002411.29","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200502078"},{"key":"2025090312053779000_8.2.e002411.30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160145","article-title":"Targeting tumor necrosis factor-\u03b1 with adalimumab: effects on endothelial activation and monocyte adhesion","volume":"11","author":"Oberoi","year":"2016","journal-title":"PLoS One"},{"key":"2025090312053779000_8.2.e002411.31","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.40"},{"key":"2025090312053779000_8.2.e002411.32","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.116.307736"},{"key":"2025090312053779000_8.2.e002411.33","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1161\/ATVBAHA.120.315754","article-title":"Thrombus structural composition in cardiovascular disease","volume":"41","author":"Alkarithi","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025090312053779000_8.2.e002411.34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1161\/ATVBAHA.120.315421","article-title":"Role of LOX-1 (lectin-like oxidized low-density lipoprotein receptor 1) as a cardiovascular risk predictor: mechanistic insight and potential clinical use","volume":"41","author":"Barreto","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025090312053779000_8.2.e002411.35","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107971"},{"key":"2025090312053779000_8.2.e002411.36","doi-asserted-by":"publisher","DOI":"10.1038\/nm1626"},{"key":"2025090312053779000_8.2.e002411.37","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-574491"},{"key":"2025090312053779000_8.2.e002411.38","doi-asserted-by":"publisher","DOI":"10.1126\/science.1174621"},{"key":"2025090312053779000_8.2.e002411.39","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-631259"},{"key":"2025090312053779000_8.2.e002411.40","doi-asserted-by":"publisher","DOI":"10.1159\/000112639"},{"key":"2025090312053779000_8.2.e002411.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.08.069"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2022-002411","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T19:05:47Z","timestamp":1756926347000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2022-002411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,9,16]]},"published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1136\/rmdopen-2022-002411"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2022-002411","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}